Pictet Asset Management Holding Sa Biocryst Pharmaceuticals Inc Transaction History
Pictet Asset Management Holding Sa
- $98.2 Billion
- Q3 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,196,319 shares of BCRX stock, worth $8.47 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,196,319
Previous 969,041
23.45%
Holding current value
$8.47 Million
Previous $8.68 Million
4.58%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding BCRX
# of Institutions
311Shares Held
200MCall Options Held
640KPut Options Held
507K-
Vanguard Group Inc Valley Forge, PA21.8MShares$154 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$141 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY12.2MShares$86.2 Million1.72% of portfolio
-
State Street Corp Boston, MA9.81MShares$69.4 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.39MShares$66.5 Million6.02% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.32B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...